在患有帕金森病和尿路症状的患者中改变了域特异性条状功能连接性
Noemi Piramide1, Rosa De Micco1, Federica Di Nardo1
1Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Napoli, Italy.
Journal of neural transmission (Vienna, Austria : 1996)
|April 25, 2024
概括
患有尿路症状的早期帕金森病 (PD) 患者表现出明显的大脑连接变化. 功能连接 (FC) 的这些变化可能会影响感官处理和运动控制,有助于量身定制的治疗.
科学领域:
- 神经成像是一种神经成像.
- 运动障碍 运动障碍
- 神经学 神经学
背景情况:
- 尿路症状在早期帕金森病 (PD) 中很常见.
- 在早期PD中,这些症状与大脑功能连接 (FC) 之间的关系尚未完全理解.
- 在早期PD中,调查与尿路症状相关的条状功能连接性改变至关重要.
研究的目的:
- 为了研究尿路症状和全脑静止状态功能连接 (FC) 变化在不同的条形状子区域之间的关联.
- 在患有尿路功能障碍的早期帕金森病患者中识别大脑连接变化的特定模式.
主要方法:
- 招募了79名从未使用过药物的PD患者 (45人有尿路症状,34人没有) 和38名健康对照 (HC).
- 使用非运动性症状尺度 - 域7评估尿路症状.
- 在整个大脑中使用预定义的条纹子区域 (感官运动,边缘,认知) 进行了基于种子的FC分析.
主要成果:
- 患有尿路症状的PD患者 (PD-尿路+) 与没有尿路症状的PD患者 (PD-尿路-) 相比,在条纹区域和运动/前运动区域之间增加了FC,以及insula/前背侧前额皮层 (PFC).
- 与HCs相比,PD-urinary+患者在条状区域和表层,岛屿和带状皮层之间显示出降低的FC.
- 这些发现表明,在患有尿路症状的PD患者中,有特定的条纹功能连接性改变.
结论:
- 一种明显的纹状功能连接 (FC) 改变模式与早期帕金森病的尿路症状有关.
- 这些变化可能与刺激感知和感觉运动整合的改变有关.
- 这些发现可能有助于为患有尿路功能障碍的PD患者制定定制的康复和神经调节策略.
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537


